BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11380390)

  • 1. CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.
    Fiumara P; Younes A
    Br J Haematol; 2001 May; 113(2):265-74. PubMed ID: 11380390
    [No Abstract]   [Full Text] [Related]  

  • 2. CD40-CD40 ligand: a multifunctional receptor-ligand pair.
    Van Kooten C; Banchereau J
    Adv Immunol; 1996; 61():1-77. PubMed ID: 8834494
    [No Abstract]   [Full Text] [Related]  

  • 3. Why would the incidence of HIV-associated Hodgkin lymphoma increase in the setting of improved immunity?
    Gloghini A; Carbone A
    Int J Cancer; 2007 Jun; 120(12):2753-4. PubMed ID: 17330236
    [No Abstract]   [Full Text] [Related]  

  • 4. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
    Travert M; Ame-Thomas P; Pangault C; Morizot A; Micheau O; Semana G; Lamy T; Fest T; Tarte K; Guillaudeux T
    J Immunol; 2008 Jul; 181(2):1001-11. PubMed ID: 18606651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B cells express functional TRAIL/Apo-2 ligand after CpG-containing oligodeoxynucleotide stimulation.
    Kemp TJ; Moore JM; Griffith TS
    J Immunol; 2004 Jul; 173(2):892-9. PubMed ID: 15240676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
    Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
    J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fortifying B cells with CD154: an engaging tale of many hues.
    Gordon J; Pound JD
    Immunology; 2000 Jul; 100(3):269-80. PubMed ID: 10929048
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment.
    Aldinucci D; Gloghini A; Pinto A; Colombatti A; Carbone A
    Leuk Lymphoma; 2012 Feb; 53(2):195-201. PubMed ID: 21756027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
    Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.
    Oshima K; Yanase N; Ibukiyama C; Yamashina A; Kayagaki N; Yagita H; Mizuguchi J
    Cytokine; 2001 May; 14(4):193-201. PubMed ID: 11448118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
    Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
    J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma.
    Aldinucci D; Rapana' B; Olivo K; Lorenzon D; Gloghini A; Colombatti A; Carbone A
    Br J Haematol; 2010 Jan; 148(1):115-8. PubMed ID: 19821826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF:TNF-R T-Cell costimulatory pathways in transplantation.
    Yamada A; Salama AD; Najafian N; Auchincloss H; Sayegh MH
    Transplant Proc; 2001; 33(7-8):3070-1. PubMed ID: 11750320
    [No Abstract]   [Full Text] [Related]  

  • 14. CD40-CD40 ligand.
    van Kooten C; Banchereau J
    J Leukoc Biol; 2000 Jan; 67(1):2-17. PubMed ID: 10647992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 and its ligand in cell-mediated immunity.
    Noelle RJ
    Agents Actions Suppl; 1998; 49():17-22. PubMed ID: 9426824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells.
    Baccam M; Bishop GA
    Eur J Immunol; 1999 Dec; 29(12):3855-66. PubMed ID: 10601993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro.
    Vecchiarelli A; Retini C; Pietrella D; Monari C; Kozel TR
    Eur J Immunol; 2000 May; 30(5):1385-93. PubMed ID: 10820385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
    Walczak H; Krammer PH
    Exp Cell Res; 2000 Apr; 256(1):58-66. PubMed ID: 10739652
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles virus and dendritic cell functions: how specific response cohabits with immunosuppression.
    Servet-Delprat C; Vidalain PO; Valentin H; Rabourdin-Combe C
    Curr Top Microbiol Immunol; 2003; 276():103-23. PubMed ID: 12797445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.
    Clodi K; Wimmer D; Li Y; Goodwin R; Jaeger U; Mann G; Gadner H; Younes A
    Br J Haematol; 2000 Nov; 111(2):580-6. PubMed ID: 11122106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.